Joaquin Espinosa
Concepts (472)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 33 | 2026 | 529 | 8.620 |
Why?
| | Tumor Suppressor Protein p53 | 17 | 2025 | 530 | 4.380 |
Why?
| | Transcription, Genetic | 13 | 2021 | 1432 | 2.000 |
Why?
| | Cyclin-Dependent Kinases | 7 | 2022 | 121 | 1.830 |
Why?
| | Transcriptome | 7 | 2026 | 1068 | 1.800 |
Why?
| | Transcriptional Activation | 7 | 2023 | 369 | 1.640 |
Why?
| | Neoplasms | 12 | 2026 | 2954 | 1.630 |
Why?
| | Proteome | 6 | 2026 | 520 | 1.550 |
Why?
| | Janus Kinase Inhibitors | 2 | 2024 | 27 | 1.490 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2024 | 43 | 1.410 |
Why?
| | Piperidines | 2 | 2024 | 225 | 1.340 |
Why?
| | Interferons | 5 | 2026 | 186 | 1.340 |
Why?
| | Pyrimidines | 3 | 2024 | 532 | 1.240 |
Why?
| | Receptors, Interferon | 3 | 2026 | 60 | 1.010 |
Why?
| | Hypoxia | 3 | 2026 | 1211 | 1.010 |
Why?
| | Common Data Elements | 1 | 2026 | 18 | 0.960 |
Why?
| | Human Development | 1 | 2025 | 22 | 0.900 |
Why?
| | Genomics | 2 | 2021 | 853 | 0.890 |
Why?
| | Metabolome | 3 | 2026 | 390 | 0.880 |
Why?
| | Antineoplastic Agents | 5 | 2025 | 2219 | 0.860 |
Why?
| | Gene Regulatory Networks | 2 | 2021 | 319 | 0.860 |
Why?
| | Immunoglobulins | 1 | 2025 | 162 | 0.830 |
Why?
| | Erythropoiesis | 1 | 2024 | 57 | 0.830 |
Why?
| | Heme | 1 | 2024 | 90 | 0.800 |
Why?
| | Blood-Brain Barrier | 1 | 2025 | 169 | 0.780 |
Why?
| | Gene Expression Regulation, Neoplastic | 8 | 2021 | 1432 | 0.760 |
Why?
| | Protein Phosphatase 2C | 1 | 2022 | 15 | 0.750 |
Why?
| | Interferon-alpha | 3 | 2020 | 201 | 0.720 |
Why?
| | Cell Death | 2 | 2025 | 379 | 0.710 |
Why?
| | Transcription Factors | 9 | 2023 | 1730 | 0.700 |
Why?
| | Humans | 78 | 2026 | 146342 | 0.700 |
Why?
| | Molecular Targeted Therapy | 1 | 2025 | 447 | 0.690 |
Why?
| | Blood | 1 | 2022 | 107 | 0.690 |
Why?
| | Heart Defects, Congenital | 3 | 2026 | 923 | 0.680 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 15 | 0.680 |
Why?
| | Artificial Intelligence | 1 | 2026 | 389 | 0.670 |
Why?
| | Genes, Tumor Suppressor | 1 | 2021 | 84 | 0.650 |
Why?
| | Apoptosis | 11 | 2025 | 2439 | 0.640 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 6 | 2025 | 66 | 0.630 |
Why?
| | Oncogenes | 1 | 2021 | 113 | 0.630 |
Why?
| | Databases, Genetic | 1 | 2021 | 239 | 0.620 |
Why?
| | Kynurenine | 2 | 2023 | 114 | 0.610 |
Why?
| | Sex Characteristics | 1 | 2025 | 801 | 0.600 |
Why?
| | Trisomy | 2 | 2019 | 79 | 0.590 |
Why?
| | Signal Transduction | 9 | 2024 | 5246 | 0.570 |
Why?
| | Tumor Suppressor Proteins | 2 | 2018 | 315 | 0.560 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 190 | 0.550 |
Why?
| | Cyclin-Dependent Kinase 8 | 6 | 2022 | 49 | 0.550 |
Why?
| | Autoimmunity | 2 | 2023 | 925 | 0.520 |
Why?
| | Animals | 32 | 2026 | 38107 | 0.510 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 416 | 0.510 |
Why?
| | Case-Control Studies | 7 | 2025 | 3647 | 0.500 |
Why?
| | CD57 Antigens | 1 | 2016 | 18 | 0.470 |
Why?
| | Abatacept | 1 | 2016 | 56 | 0.460 |
Why?
| | Cell Proliferation | 7 | 2025 | 2502 | 0.450 |
Why?
| | Adult | 20 | 2026 | 41087 | 0.430 |
Why?
| | Mice | 18 | 2026 | 18297 | 0.420 |
Why?
| | Interferon-gamma | 3 | 2026 | 781 | 0.410 |
Why?
| | Cell Line, Tumor | 9 | 2023 | 3545 | 0.410 |
Why?
| | Female | 33 | 2026 | 79499 | 0.400 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 628 | 0.390 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2024 | 299 | 0.380 |
Why?
| | Proteomics | 4 | 2025 | 1203 | 0.380 |
Why?
| | Cyclins | 3 | 2022 | 77 | 0.370 |
Why?
| | Gene Expression Profiling | 5 | 2024 | 1792 | 0.360 |
Why?
| | Male | 25 | 2026 | 73396 | 0.360 |
Why?
| | Young Adult | 10 | 2026 | 14330 | 0.360 |
Why?
| | Graft Rejection | 1 | 2016 | 516 | 0.360 |
Why?
| | Datasets as Topic | 2 | 2022 | 120 | 0.340 |
Why?
| | Adolescent | 11 | 2026 | 22557 | 0.340 |
Why?
| | Immunosuppressive Agents | 1 | 2016 | 829 | 0.330 |
Why?
| | Alzheimer Disease | 3 | 2025 | 641 | 0.320 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2023 | 1150 | 0.320 |
Why?
| | Cell Differentiation | 3 | 2024 | 1982 | 0.320 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 630 | 0.310 |
Why?
| | RNA Polymerase II | 4 | 2019 | 347 | 0.310 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2019 | 220 | 0.310 |
Why?
| | Cell Line | 5 | 2021 | 2814 | 0.300 |
Why?
| | Child, Preschool | 8 | 2026 | 11913 | 0.300 |
Why?
| | Kidney Transplantation | 1 | 2016 | 735 | 0.290 |
Why?
| | Mediator Complex | 3 | 2022 | 61 | 0.290 |
Why?
| | Biomarkers | 5 | 2025 | 4340 | 0.280 |
Why?
| | DNA-Binding Proteins | 4 | 2016 | 1468 | 0.260 |
Why?
| | Early Detection of Cancer | 2 | 2026 | 506 | 0.260 |
Why?
| | Proto-Oncogene Proteins | 2 | 2023 | 616 | 0.250 |
Why?
| | Child | 11 | 2026 | 22693 | 0.250 |
Why?
| | Promoter Regions, Genetic | 4 | 2013 | 1242 | 0.250 |
Why?
| | Gene Expression Regulation | 3 | 2012 | 2599 | 0.250 |
Why?
| | Trypanosoma cruzi | 4 | 2000 | 38 | 0.250 |
Why?
| | Flow Cytometry | 3 | 2019 | 1163 | 0.240 |
Why?
| | Cytokines | 5 | 2024 | 2081 | 0.240 |
Why?
| | Disease Models, Animal | 7 | 2026 | 4580 | 0.240 |
Why?
| | Phenotype | 2 | 2026 | 3206 | 0.240 |
Why?
| | Candidiasis, Oral | 1 | 2026 | 19 | 0.230 |
Why?
| | Positive Transcriptional Elongation Factor B | 1 | 2006 | 28 | 0.230 |
Why?
| | Middle Aged | 13 | 2026 | 36619 | 0.230 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2009 | 104 | 0.230 |
Why?
| | Cell Cycle | 2 | 2008 | 595 | 0.230 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2026 | 147 | 0.230 |
Why?
| | Platelet Activation | 1 | 2026 | 99 | 0.230 |
Why?
| | Phosphorylation | 4 | 2022 | 1724 | 0.220 |
Why?
| | Medical Informatics | 1 | 2026 | 102 | 0.220 |
Why?
| | Natural Language Processing | 1 | 2026 | 103 | 0.220 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2675 | 0.220 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2025 | 158 | 0.210 |
Why?
| | Metabolomics | 2 | 2021 | 738 | 0.210 |
Why?
| | Heart | 2 | 2025 | 626 | 0.210 |
Why?
| | Mechanotransduction, Cellular | 1 | 2025 | 121 | 0.210 |
Why?
| | Protein Binding | 5 | 2021 | 2244 | 0.210 |
Why?
| | Polymerase Chain Reaction | 2 | 2019 | 1031 | 0.210 |
Why?
| | Hemoglobin SC Disease | 1 | 2023 | 14 | 0.200 |
Why?
| | Erythropoietin | 1 | 2024 | 100 | 0.190 |
Why?
| | Homeodomain Proteins | 2 | 2019 | 525 | 0.190 |
Why?
| | Liposarcoma | 1 | 2023 | 31 | 0.190 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 212 | 0.190 |
Why?
| | Glutamine | 1 | 2023 | 110 | 0.190 |
Why?
| | Hypertension, Pulmonary | 2 | 2026 | 1957 | 0.190 |
Why?
| | Cyclin C | 1 | 2022 | 2 | 0.190 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2022 | 34 | 0.190 |
Why?
| | Growth Disorders | 1 | 2022 | 89 | 0.180 |
Why?
| | Diabetic Neuropathies | 1 | 2023 | 101 | 0.180 |
Why?
| | Centrosome | 2 | 2022 | 67 | 0.180 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 67 | 0.180 |
Why?
| | Nuclear Proteins | 4 | 2023 | 740 | 0.180 |
Why?
| | Gene Silencing | 1 | 2023 | 200 | 0.180 |
Why?
| | Nervous System Diseases | 1 | 2025 | 288 | 0.170 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 169 | 0.170 |
Why?
| | Acetyltransferases | 1 | 2001 | 27 | 0.170 |
Why?
| | Up-Regulation | 3 | 2021 | 841 | 0.170 |
Why?
| | Medulloblastoma | 1 | 2023 | 208 | 0.170 |
Why?
| | Access to Information | 1 | 2021 | 46 | 0.170 |
Why?
| | Stress, Physiological | 1 | 2024 | 450 | 0.160 |
Why?
| | Hematopoiesis | 2 | 2021 | 195 | 0.160 |
Why?
| | Cilia | 2 | 2022 | 171 | 0.160 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 26 | 0.160 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 31 | 0.160 |
Why?
| | Azetidines | 1 | 2020 | 45 | 0.160 |
Why?
| | RNA, Messenger | 4 | 2021 | 2791 | 0.160 |
Why?
| | Models, Biological | 1 | 2008 | 1761 | 0.160 |
Why?
| | MicroRNAs | 2 | 2018 | 699 | 0.160 |
Why?
| | Data Mining | 1 | 2021 | 113 | 0.160 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 320 | 0.160 |
Why?
| | Doxorubicin | 3 | 2007 | 416 | 0.160 |
Why?
| | Eosinophilic Esophagitis | 1 | 2024 | 333 | 0.150 |
Why?
| | Autoantigens | 1 | 2023 | 426 | 0.150 |
Why?
| | Quinolinic Acid | 1 | 2019 | 7 | 0.150 |
Why?
| | Connective Tissue Diseases | 1 | 2020 | 85 | 0.150 |
Why?
| | Heart Diseases | 1 | 2023 | 343 | 0.150 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 25 | 0.150 |
Why?
| | DNA, Protozoan | 1 | 1999 | 32 | 0.150 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 56 | 0.150 |
Why?
| | Liver | 2 | 2026 | 1864 | 0.150 |
Why?
| | Anemia, Sickle Cell | 1 | 2023 | 324 | 0.150 |
Why?
| | Transcription Factor AP-1 | 1 | 1999 | 76 | 0.150 |
Why?
| | Sex Determination Analysis | 1 | 2019 | 10 | 0.140 |
Why?
| | Preimplantation Diagnosis | 1 | 2019 | 7 | 0.140 |
Why?
| | Protein Domains | 2 | 2017 | 315 | 0.140 |
Why?
| | Blastocyst | 1 | 2019 | 50 | 0.140 |
Why?
| | Neurons | 2 | 2025 | 1668 | 0.140 |
Why?
| | Protozoan Proteins | 1 | 1999 | 88 | 0.140 |
Why?
| | Occult Blood | 1 | 2018 | 41 | 0.140 |
Why?
| | Tibia | 1 | 2020 | 177 | 0.140 |
Why?
| | Calcinosis | 1 | 2020 | 231 | 0.140 |
Why?
| | Cognitive Dysfunction | 1 | 2025 | 481 | 0.140 |
Why?
| | Cell Survival | 2 | 2021 | 1105 | 0.140 |
Why?
| | Coinfection | 1 | 2020 | 143 | 0.140 |
Why?
| | Genome, Human | 1 | 2021 | 431 | 0.140 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2018 | 15 | 0.140 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 66 | 0.140 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 32 | 0.140 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 18 | 0.140 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 76 | 0.140 |
Why?
| | Embryo, Mammalian | 1 | 2019 | 230 | 0.130 |
Why?
| | Kidney Function Tests | 2 | 2016 | 156 | 0.130 |
Why?
| | Mice, Inbred C57BL | 5 | 2020 | 6034 | 0.130 |
Why?
| | Stem Cell Niche | 1 | 2018 | 57 | 0.130 |
Why?
| | Bacterial Infections | 1 | 2020 | 247 | 0.130 |
Why?
| | Epithelial Cells | 1 | 2024 | 1119 | 0.130 |
Why?
| | Electronic Health Records | 1 | 2026 | 1210 | 0.130 |
Why?
| | Receptor, Notch1 | 1 | 2018 | 62 | 0.130 |
Why?
| | Cell Lineage | 1 | 2019 | 377 | 0.130 |
Why?
| | Hypersensitivity | 1 | 2020 | 253 | 0.130 |
Why?
| | Inpatients | 1 | 2022 | 540 | 0.130 |
Why?
| | Horses | 1 | 2019 | 229 | 0.130 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 455 | 0.130 |
Why?
| | Binding Sites | 3 | 2014 | 1309 | 0.130 |
Why?
| | Reminder Systems | 1 | 2018 | 149 | 0.130 |
Why?
| | Inflammation | 2 | 2020 | 2919 | 0.130 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 186 | 0.130 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2023 | 931 | 0.130 |
Why?
| | Cellular Senescence | 1 | 2019 | 225 | 0.130 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 4 | 0.130 |
Why?
| | Hedgehog Proteins | 1 | 2018 | 194 | 0.130 |
Why?
| | Prospective Studies | 3 | 2025 | 8123 | 0.120 |
Why?
| | Proteins | 1 | 2023 | 1022 | 0.120 |
Why?
| | Febrile Neutropenia | 1 | 2016 | 6 | 0.120 |
Why?
| | Cohort Studies | 2 | 2026 | 6077 | 0.120 |
Why?
| | Histidine Kinase | 1 | 2016 | 34 | 0.120 |
Why?
| | T-Lymphocytes | 2 | 2022 | 2012 | 0.120 |
Why?
| | Osteoarthritis, Knee | 1 | 2020 | 291 | 0.120 |
Why?
| | Antigens | 1 | 2018 | 350 | 0.120 |
Why?
| | Sulfonamides | 1 | 2020 | 594 | 0.120 |
Why?
| | Osteosarcoma | 1 | 2017 | 100 | 0.120 |
Why?
| | Exosomes | 1 | 2017 | 104 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 2 | 2020 | 983 | 0.120 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 415 | 0.120 |
Why?
| | Proteolysis | 1 | 2017 | 174 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 158 | 0.110 |
Why?
| | HCT116 Cells | 3 | 2019 | 78 | 0.110 |
Why?
| | Chromatin | 4 | 2016 | 559 | 0.110 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 259 | 0.110 |
Why?
| | Lymphocyte Activation | 1 | 2019 | 1137 | 0.110 |
Why?
| | Autophagy | 1 | 2018 | 290 | 0.110 |
Why?
| | Follow-Up Studies | 4 | 2020 | 5439 | 0.110 |
Why?
| | Neurofilament Proteins | 3 | 2025 | 83 | 0.110 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 93 | 0.110 |
Why?
| | Drug Resistance | 1 | 2016 | 145 | 0.110 |
Why?
| | Allografts | 1 | 2016 | 151 | 0.110 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 597 | 0.110 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2019 | 1160 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 432 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 403 | 0.110 |
Why?
| | Aging | 1 | 2025 | 1996 | 0.110 |
Why?
| | Patient Participation | 1 | 2018 | 457 | 0.110 |
Why?
| | Gene Expression | 1 | 2019 | 1463 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2017 | 272 | 0.100 |
Why?
| | Azepines | 1 | 2015 | 104 | 0.100 |
Why?
| | Repressor Proteins | 1 | 2017 | 430 | 0.100 |
Why?
| | Infant | 3 | 2025 | 10114 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2018 | 728 | 0.100 |
Why?
| | Acetylation | 2 | 2007 | 262 | 0.100 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2013 | 11 | 0.100 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2016 | 752 | 0.100 |
Why?
| | Fibroblasts | 1 | 2019 | 1034 | 0.100 |
Why?
| | Mitogens | 1 | 2013 | 55 | 0.100 |
Why?
| | Bile Acids and Salts | 2 | 2026 | 163 | 0.100 |
Why?
| | Down-Regulation | 1 | 2015 | 614 | 0.100 |
Why?
| | Spain | 3 | 2025 | 50 | 0.100 |
Why?
| | Prognosis | 3 | 2019 | 4351 | 0.100 |
Why?
| | Immunologic Memory | 1 | 2016 | 369 | 0.100 |
Why?
| | Graft Survival | 1 | 2016 | 523 | 0.100 |
Why?
| | Disease Progression | 1 | 2021 | 2867 | 0.090 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1712 | 0.090 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 174 | 0.090 |
Why?
| | Feedback, Physiological | 1 | 2012 | 79 | 0.090 |
Why?
| | Amphotericin B | 1 | 2012 | 36 | 0.090 |
Why?
| | Obesity | 1 | 2026 | 3131 | 0.090 |
Why?
| | Tumor Cells, Cultured | 3 | 2019 | 882 | 0.090 |
Why?
| | Glomerular Filtration Rate | 1 | 2016 | 745 | 0.090 |
Why?
| | United States | 2 | 2026 | 16136 | 0.090 |
Why?
| | RNA Stability | 1 | 2012 | 119 | 0.090 |
Why?
| | Antifungal Agents | 1 | 2012 | 153 | 0.090 |
Why?
| | Protein Structure, Tertiary | 2 | 2006 | 834 | 0.080 |
Why?
| | Colorectal Neoplasms | 1 | 2018 | 874 | 0.080 |
Why?
| | Mass Screening | 1 | 2018 | 1307 | 0.080 |
Why?
| | Risk Factors | 3 | 2025 | 10921 | 0.080 |
Why?
| | Kidney Failure, Chronic | 1 | 2016 | 589 | 0.080 |
Why?
| | HeLa Cells | 3 | 2013 | 636 | 0.070 |
Why?
| | Sirtuins | 1 | 2010 | 50 | 0.070 |
Why?
| | Imidazoles | 2 | 2023 | 245 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2008 | 759 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 457 | 0.070 |
Why?
| | S Phase | 1 | 2009 | 77 | 0.070 |
Why?
| | Histones | 2 | 2007 | 670 | 0.070 |
Why?
| | Protamine Kinase | 1 | 2008 | 8 | 0.070 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2008 | 18 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2623 | 0.070 |
Why?
| | Hydroxyurea | 2 | 2023 | 36 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2921 | 0.070 |
Why?
| | Kidney Diseases | 1 | 2012 | 428 | 0.070 |
Why?
| | Piperazines | 2 | 2023 | 368 | 0.070 |
Why?
| | Glial Fibrillary Acidic Protein | 2 | 2025 | 124 | 0.060 |
Why?
| | RNA | 1 | 2014 | 926 | 0.060 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2007 | 42 | 0.060 |
Why?
| | Multiprotein Complexes | 1 | 2008 | 168 | 0.060 |
Why?
| | Protein Kinases | 1 | 2009 | 311 | 0.060 |
Why?
| | Formaldehyde | 1 | 2007 | 66 | 0.060 |
Why?
| | Radiation, Ionizing | 1 | 2007 | 84 | 0.060 |
Why?
| | Glycolysis | 2 | 2024 | 342 | 0.060 |
Why?
| | Genome-Wide Association Study | 2 | 2025 | 1537 | 0.060 |
Why?
| | RNA Precursors | 1 | 2007 | 155 | 0.060 |
Why?
| | DNA | 2 | 2006 | 1421 | 0.060 |
Why?
| | Fluorouracil | 1 | 2007 | 231 | 0.060 |
Why?
| | Kinetics | 2 | 2007 | 1553 | 0.060 |
Why?
| | Endocardial Cushions | 1 | 2025 | 7 | 0.060 |
Why?
| | High Mobility Group Proteins | 1 | 2006 | 45 | 0.060 |
Why?
| | Transcription Factors, TFII | 1 | 2006 | 44 | 0.060 |
Why?
| | Critical Illness | 1 | 2012 | 908 | 0.060 |
Why?
| | Transcriptional Elongation Factors | 1 | 2006 | 40 | 0.060 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2006 | 139 | 0.060 |
Why?
| | Transcription Factor TFIIH | 1 | 2006 | 40 | 0.060 |
Why?
| | Protein Transport | 1 | 2007 | 443 | 0.060 |
Why?
| | Candida albicans | 1 | 2026 | 62 | 0.060 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 70 | 0.060 |
Why?
| | Serine | 1 | 2006 | 142 | 0.060 |
Why?
| | SEER Program | 1 | 2026 | 233 | 0.050 |
Why?
| | Mice, Knockout | 3 | 2019 | 3125 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2418 | 0.050 |
Why?
| | Myocytes, Cardiac | 2 | 2025 | 544 | 0.050 |
Why?
| | Kidney | 1 | 2012 | 1498 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2006 | 391 | 0.050 |
Why?
| | Glucose | 1 | 2010 | 1053 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2026 | 339 | 0.050 |
Why?
| | Vascular Remodeling | 1 | 2026 | 208 | 0.050 |
Why?
| | Aged | 6 | 2025 | 26432 | 0.050 |
Why?
| | Hemoglobin, Sickle | 1 | 2023 | 20 | 0.050 |
Why?
| | Headache | 1 | 2025 | 150 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 974 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2019 | 930 | 0.050 |
Why?
| | Intermediate Filaments | 1 | 2023 | 16 | 0.050 |
Why?
| | Glutamates | 1 | 2023 | 66 | 0.050 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 23 | 0.050 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 42 | 0.050 |
Why?
| | Proline | 1 | 2023 | 79 | 0.050 |
Why?
| | L-Selectin | 1 | 2023 | 27 | 0.050 |
Why?
| | Perforin | 1 | 2023 | 22 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 217 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2026 | 17438 | 0.050 |
Why?
| | Patient Acuity | 1 | 2023 | 46 | 0.050 |
Why?
| | Blood Platelets | 1 | 2026 | 382 | 0.050 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 269 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2025 | 8391 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 166 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 155 | 0.050 |
Why?
| | Esophagus | 1 | 2024 | 260 | 0.040 |
Why?
| | Cells, Cultured | 3 | 2018 | 4118 | 0.040 |
Why?
| | Hemolysis | 1 | 2023 | 242 | 0.040 |
Why?
| | Centrioles | 1 | 2022 | 48 | 0.040 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 146 | 0.040 |
Why?
| | DNA Footprinting | 1 | 2001 | 33 | 0.040 |
Why?
| | Neuroimaging | 1 | 2024 | 307 | 0.040 |
Why?
| | Nitric Oxide | 2 | 1997 | 883 | 0.040 |
Why?
| | p300-CBP Transcription Factors | 1 | 2001 | 25 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2025 | 565 | 0.040 |
Why?
| | Nerve Regeneration | 1 | 2001 | 57 | 0.040 |
Why?
| | Genes, Protozoan | 1 | 2000 | 13 | 0.040 |
Why?
| | Immunoblotting | 1 | 2001 | 294 | 0.040 |
Why?
| | Histone Acetyltransferases | 1 | 2001 | 57 | 0.040 |
Why?
| | Clonal Evolution | 1 | 2021 | 47 | 0.040 |
Why?
| | RNA Helicases | 1 | 2000 | 31 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 2022 | 271 | 0.040 |
Why?
| | Microtubules | 1 | 2022 | 226 | 0.040 |
Why?
| | Neuropsychological Tests | 1 | 2025 | 1149 | 0.040 |
Why?
| | Oligonucleotide Probes | 1 | 1999 | 48 | 0.040 |
Why?
| | Electrophoresis | 1 | 1999 | 31 | 0.040 |
Why?
| | Heterozygote | 1 | 2020 | 311 | 0.040 |
Why?
| | Vesiculovirus | 1 | 2019 | 17 | 0.040 |
Why?
| | Interferon Type I | 1 | 2020 | 147 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2020 | 180 | 0.040 |
Why?
| | Purines | 1 | 2020 | 188 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 193 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 1999 | 51 | 0.040 |
Why?
| | Genetic Testing | 1 | 2022 | 492 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2019 | 68 | 0.040 |
Why?
| | Veterinary Sports Medicine | 1 | 2019 | 1 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2001 | 237 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 12 | 0.040 |
Why?
| | Argentina | 1 | 2019 | 28 | 0.040 |
Why?
| | Biopsy | 2 | 2019 | 1075 | 0.040 |
Why?
| | Postal Service | 1 | 2018 | 27 | 0.040 |
Why?
| | Prevalence | 1 | 2026 | 2861 | 0.040 |
Why?
| | Osteotomy | 1 | 2020 | 138 | 0.040 |
Why?
| | Immunotherapy | 1 | 2024 | 671 | 0.040 |
Why?
| | Breeding | 1 | 2019 | 64 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 1999 | 193 | 0.040 |
Why?
| | Myelopoiesis | 1 | 2018 | 10 | 0.030 |
Why?
| | Immunotherapy, Adoptive | 1 | 2022 | 356 | 0.030 |
Why?
| | Embryo Transfer | 1 | 2019 | 45 | 0.030 |
Why?
| | Lymphopoiesis | 1 | 2018 | 27 | 0.030 |
Why?
| | DNA, Single-Stranded | 1 | 1999 | 119 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 83 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2001 | 663 | 0.030 |
Why?
| | Arginine | 2 | 1997 | 264 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2026 | 1591 | 0.030 |
Why?
| | Commerce | 1 | 2019 | 80 | 0.030 |
Why?
| | Mice, SCID | 1 | 2019 | 360 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2018 | 133 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 52 | 0.030 |
Why?
| | Amyloid beta-Peptides | 1 | 2020 | 251 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2025 | 2240 | 0.030 |
Why?
| | omega-N-Methylarginine | 1 | 1997 | 29 | 0.030 |
Why?
| | Antibodies | 1 | 1999 | 400 | 0.030 |
Why?
| | Rats | 1 | 2025 | 5586 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2025 | 3017 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 598 | 0.030 |
Why?
| | Blotting, Western | 1 | 1999 | 1177 | 0.030 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 18 | 0.030 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 41 | 0.030 |
Why?
| | Pyrazoles | 1 | 2020 | 517 | 0.030 |
Why?
| | Epilepsy | 1 | 2001 | 400 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2025 | 2488 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 366 | 0.030 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 72 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2019 | 693 | 0.030 |
Why?
| | Mitosis | 1 | 2017 | 195 | 0.030 |
Why?
| | Knee Joint | 1 | 2020 | 453 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1244 | 0.030 |
Why?
| | African Swine Fever | 1 | 1995 | 1 | 0.030 |
Why?
| | African Swine Fever Virus | 1 | 1995 | 1 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 18 | 0.030 |
Why?
| | Cholesterol | 1 | 2017 | 411 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 406 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 57 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 141 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 844 | 0.030 |
Why?
| | Hospitalization | 1 | 2025 | 2475 | 0.030 |
Why?
| | Complement System Proteins | 1 | 2017 | 326 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 2092 | 0.020 |
Why?
| | Cell Movement | 1 | 2018 | 951 | 0.020 |
Why?
| | Genes, Immediate-Early | 1 | 2013 | 25 | 0.020 |
Why?
| | Genes, ras | 1 | 2013 | 70 | 0.020 |
Why?
| | Protein Conformation | 1 | 2016 | 916 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 147 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2017 | 960 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 2018 | 887 | 0.020 |
Why?
| | Lung | 1 | 2026 | 4122 | 0.020 |
Why?
| | Oxidative Stress | 1 | 1999 | 1369 | 0.020 |
Why?
| | Mycoses | 1 | 2012 | 87 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1339 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 1995 | 422 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1827 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 750 | 0.020 |
Why?
| | Creatinine | 1 | 2012 | 511 | 0.020 |
Why?
| | Glucose Transporter Type 1 | 1 | 2010 | 49 | 0.020 |
Why?
| | Cell Respiration | 1 | 2010 | 104 | 0.020 |
Why?
| | Daunorubicin | 1 | 2009 | 25 | 0.020 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2009 | 16 | 0.020 |
Why?
| | Checkpoint Kinase 2 | 1 | 2009 | 27 | 0.020 |
Why?
| | Checkpoint Kinase 1 | 1 | 2009 | 27 | 0.020 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 69 | 0.020 |
Why?
| | Coenzymes | 1 | 2008 | 23 | 0.020 |
Why?
| | Caffeine | 1 | 2009 | 77 | 0.020 |
Why?
| | Brain | 1 | 2001 | 2991 | 0.020 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 12 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2008 | 389 | 0.020 |
Why?
| | Genes, myc | 1 | 2007 | 45 | 0.020 |
Why?
| | RNA Caps | 1 | 2007 | 33 | 0.020 |
Why?
| | Poly A | 1 | 2007 | 49 | 0.020 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2007 | 24 | 0.020 |
Why?
| | DNA Replication | 1 | 2009 | 248 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 266 | 0.020 |
Why?
| | Dizocilpine Maleate | 2 | 1997 | 24 | 0.010 |
Why?
| | Cyclic GMP | 2 | 1997 | 88 | 0.010 |
Why?
| | Pregnancy | 1 | 2019 | 7230 | 0.010 |
Why?
| | Nitric Oxide Synthase | 2 | 1997 | 233 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2008 | 729 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1361 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2020 | 11821 | 0.010 |
Why?
| | Models, Molecular | 1 | 2007 | 1574 | 0.010 |
Why?
| | Mutation | 1 | 2013 | 4093 | 0.010 |
Why?
| | Genomic Library | 1 | 2000 | 15 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2001 | 384 | 0.010 |
Why?
| | RNA, Protozoan | 1 | 2000 | 60 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2000 | 269 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 2000 | 218 | 0.010 |
Why?
| | Microtubule-Associated Proteins | 1 | 2001 | 187 | 0.010 |
Why?
| | tau Proteins | 1 | 2001 | 111 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2000 | 508 | 0.010 |
Why?
| | Cell Culture Techniques | 1 | 2001 | 371 | 0.010 |
Why?
| | Bucladesine | 1 | 1997 | 19 | 0.010 |
Why?
| | Guanosine Monophosphate | 1 | 1997 | 8 | 0.010 |
Why?
| | Guanosine Diphosphate | 1 | 1997 | 20 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2000 | 2092 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2000 | 2838 | 0.010 |
Why?
| | Amino Acid Oxidoreductases | 1 | 1995 | 19 | 0.010 |
Why?
| | Guanylate Cyclase | 1 | 1995 | 36 | 0.010 |
Why?
| | Citrulline | 1 | 1995 | 45 | 0.010 |
Why?
| | Glutamic Acid | 1 | 1997 | 255 | 0.010 |
Why?
| | Movement | 1 | 1997 | 290 | 0.010 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 1995 | 233 | 0.010 |
Why?
| | Amino Acids | 1 | 1997 | 515 | 0.010 |
Why?
| | Brain Neoplasms | 1 | 2001 | 1325 | 0.010 |
Why?
|
|
Espinosa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|